| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 供应链业务(元) | 1,987,320.72 | 4,748,829.38 | 2,697,024.64 |
| 销售药品收入(元) | 207,010,862.35 | 323,027,954.21 | 159,164,869.95 |
| 医疗服务收入(元) | 615,059,978.23 | 1,091,016,583.74 | 539,074,157.77 |
| 营业成本(元) | |||
| 供应链业务(元) | 1,855,712.19 | 4,498,120.89 | 2,498,927.18 |
| 销售药品收入(元) | 177,203,261.55 | 287,622,610.43 | 140,384,913.44 |
| 医疗服务收入(元) | 429,548,417.89 | 795,502,994.83 | 381,758,233.59 |
| 毛利(元) | |||
| 供应链业务(元) | 131,608.53 | 250,708.49 | 198,097.46 |
| 销售药品收入(元) | 29,807,600.80 | 35,405,343.78 | 18,779,956.51 |
| 医疗服务收入(元) | 185,511,560.34 | 295,513,588.91 | 157,315,924.18 |
| 毛利率(%) | |||
| 供应链业务(%) | 6.62 | 5.28 | 7.35 |
| 销售药品收入(%) | 14.40 | 10.96 | 11.80 |
| 医疗服务收入(%) | 30.16 | 27.09 | 29.18 |
| 收入构成(%) | |||
| 供应链业务(%) | 0.24 | 0.33 | 0.38 |
| 销售药品收入(%) | 25.12 | 22.77 | 22.71 |
| 医疗服务收入(%) | 74.64 | 76.90 | 76.91 |
| 毛利构成(%) | |||
| 供应链业务(%) | 0.06 | 0.08 | 0.11 |
| 销售药品收入(%) | 13.83 | 10.69 | 10.65 |
| 医疗服务收入(%) | 86.10 | 89.23 | 89.23 |